We are live on ! Find out more

KIN

Kindred Biosciences, Inc.

KIN

Delisted

KIN was delisted on the 27th of August, 2021.

41 hedge funds and large institutions have $64.1M invested in Kindred Biosciences, Inc. in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New

Increased

Maintained

Reduced

Closed

41% more capital invested

Capital invested by funds: $45.3M → $64.1M (+$18.7M)

7% less funds holding

Funds holding: 44 → 41 (-3)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders

Holders Change

-3

Holders Change %

-6.82%

% of All Funds

1.09%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

–

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	Wells Fargo San Francisco, California	+$873K
2	AI Ariel Investments Chicago, Illinois	+$590K
3	SKK Shepherd Kaplan Krochuk Boston, Massachusetts	+$137K
4	Renaissance Technologies New York	+$122K
5	Prudential Financial Newark, New Jersey	+$16.9K

Top Sellers

Rank	Fund	Capital Flow
1	JP Morgan Chase New York	-$833K
2	Fidelity Investments Boston, Massachusetts	-$480K
3	Jacobs Levy Equity Management Florham Park, New Jersey	-$33.8K
4	Goldman Sachs New York	-$19.9K
5	Morgan Stanley New York	-$15.3K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 Dimensional Fund Advisors Austin, Texas	$123K	+$8.64K	+2,044	+9%
27	27 Morgan Stanley New York	$122K	-$15.3K	-3,620	-13%
28	BA 28 BlackRock Advisors Wilmington, Delaware	$122K	-$7.5K	-1,775	-7%
29	29 Goldman Sachs New York	$118K	-$19.9K	-4,719	-17%
30	EAM 30 Evanson Asset Management Carmel, California	$83K	–	–	–
31	BG 31 BlackRock Group London, United Kingdom	$74K	–	–	–
32	32 LPL Financial San Diego, California	$70K	-$1.06K	-250	-2%
33	NFGCM 33 Norman Fields Gottscho Capital Management New York	$69K	–	–	–
34	NFA 34 Nationwide Fund Advisors Columbus, Ohio	$43K	–	–	–
35	CG 35 Cutler Group San Francisco, California	$17K	–	–	–
36	BIM 36 BlackRock Investment Management Wilmington, Delaware	$15K	–	–	–
37	BJ 37 BlackRock Japan Tokyo, Japan	$13K	-$3.08K	-728	-22%
38	38 Acadian Asset Management Boston, Massachusetts	$7K	–	–	–
39	MA 39 MUFG Americas New York	$4K	-$1.52K	-360	-34%
40	40 Bank of Montreal Toronto, Ontario, Canada	$2K	+$1.78K	+422	+2,344%
41	41 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$1K	–	–	–
42	42 JP Morgan Chase New York	–	-$833K	-235,408	Closed
43	TRCT 43 Tower Research Capital (TRC) New York	–	-$5K	-1,455	Closed
44	44 Walleye Trading New York	–	-$3K	-800	Closed

KIN Hedge Fund Activity: Q3 2016 in Review

41 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2016, worth a combined $64.1M — up 41% from $45.3M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of KIN and 0 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.

The largest buyer was Wells Fargo, adding an estimated $873K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $833K sold.

41 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q3 2016, down from 44 in Q2 2016.
Funds reported $64.1M of Kindred Biosciences, Inc. stock for Q3 2016, up 41% quarter-over-quarter.
0 funds opened new Kindred Biosciences, Inc. positions in Q3 2016 and 3 closed out, a net change of -3 holders.
The largest Kindred Biosciences, Inc. buyer in Q3 2016 was Wells Fargo, an estimated $873K added.
The largest Kindred Biosciences, Inc. seller in Q3 2016 was JP Morgan Chase, an estimated $833K sold.

Based on aggregated 13F filings for Q3 2016.

Kindred Biosciences, Inc. KIN